Latest News about Pfizer Inc

Recent news which mentions Pfizer Inc

< Previous 1 2 3 4 5 6 7 8 9

...

5 things to know before the stock market opens Friday

August 23, 2024

CNBC Daily Open: Stocks slide ahead of Powell speech

August 22, 2024

FDA approves updated Pfizer, Moderna Covid vaccines as virus surges; shots to be available within days

August 22, 2024

Healthy Returns: The race to develop combination shots targeting Covid, flu is heating up

August 20, 2024

Thursday's big stock stories: What’s likely to move the market in the next trading session

August 14, 2024

Top Wall Street analysts are bullish on these dividend stocks

August 11, 2024

Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare

August 06, 2024

Moderna beats estimates but slashes guidance on low EU sales, competitive U.S. vaccine market

August 01, 2024

Pfizer beats earnings estimates, hikes full-year outlook as drugmaker cuts costs

July 30, 2024

Pfizer's gene therapy for rare genetic bleeding disorder succeeds in late-stage trial

July 24, 2024

Op-ed: How well can AI chatbots mimic doctors in a treatment setting? We put 5 to the test

July 18, 2024

Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use

July 16, 2024

Pfizer moves forward with once-daily version of weight loss pill after setbacks

July 11, 2024

Rural retailer Tractor Supply eliminates DEI roles, Pride support and carbon emissions goals

June 28, 2024

Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline

June 28, 2024

FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections

June 17, 2024

Healthy Returns: What we know about the next round of Covid vaccines

June 12, 2024

Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial

June 10, 2024

FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach

June 07, 2024

Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big

June 07, 2024

FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product

May 31, 2024

Pfizer's drug for advanced lung cancer shows promising long-term trial results

May 31, 2024

Healthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conference

May 30, 2024

Here's how U.S. health officials are responding to bird flu in humans after second case

May 24, 2024

Pfizer aims to save $1.5 billion by 2027 in first wave of new cost cuts

May 22, 2024

Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker

May 13, 2024

Moderna says FDA delayed RSV vaccine approval to end of May

May 10, 2024

Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop combination shots

May 10, 2024

Cramer explains how to maintain a 'balanced' portfolio as the economy slows

May 07, 2024

Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales

May 01, 2024

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.